RALEIGH, N.C., March 2, 2026 - Lumexa Imaging Holdings, Inc., one of the largest outpatient imaging service providers in the United States, announced its preliminary unaudited financial results for the fourth quarter and full year of 2025. The company reported significant growth, with revenues reaching approximately $250 million for the year. In addition, Lumexa Imaging provided guidance for 2026, indicating a promising outlook for continued expansion.
Impressive Financial Performance in 2025
Lumexa Imaging's preliminary results for the fourth quarter of 2025 showcased a robust upward trajectory in both revenues and operational efficiency. For Q4 alone, the company reported revenues of around $70 million, which marks a substantial increase from $55 million in the same quarter of the previous year. This growth reflects Lumexa's strategic initiatives to broaden its service offerings and enhance patient access to imaging services. Learn more on Investopedia.
The full-year revenue of approximately $250 million represents a remarkable growth rate of 25% compared to 2024. This surge in revenue is attributed to the increased demand for outpatient imaging services, particularly in MRI and CT scans, as well as the expansion of Lumexa's facilities across North Carolina and neighboring states. The company's focus on improving patient care and reducing wait times has also contributed to its financial success.
2026 Financial Guidance Indicates Continued Growth
Looking ahead, Lumexa Imaging has provided an optimistic financial outlook for 2026. The company anticipates revenues in the range of $280 million to $300 million, representing a year-over-year growth rate of approximately 12% to 20%. This positive forecast is based on projected increases in patient volumes and the anticipated expansion of service lines in several new locations.
CEO John Peterson remarked, "We are excited about the opportunities that lie ahead. Our commitment to delivering high-quality imaging services and expanding our footprint will drive our growth in 2026. We believe the demand for outpatient imaging will continue to rise as healthcare evolves. Our focus will remain on enhancing patient experience and operational efficiency to meet this demand."
Conference Call Scheduled for Detailed Discussion
To discuss these results and the company's outlook in greater detail, Lumexa Imaging has scheduled an earnings conference call for March 15, 2026. The call will begin at 10:00 AM Eastern Time and will be accessible to the public via a live audio webcast on the company's investor relations page.
During the call, company executives will provide insights into the financial results, operational strategies, and future initiatives. Investors and analysts are encouraged to participate, as this will be an opportunity to gain deeper insights into Lumexa's performance and growth strategies. A replay of the call will be available shortly after the live event for those unable to attend.
Strategic Expansion and Technological Advancements
As part of its growth strategy, Lumexa Imaging is also investing in advanced technologies to enhance its service offerings. The company plans to introduce new imaging modalities and expand its telehealth services, allowing patients greater flexibility in accessing care. By integrating technology into its operations, Lumexa aims to improve diagnostic accuracy and expand its patient base.
Moreover, Lumexa is actively pursuing partnerships with leading healthcare providers and payers to facilitate easier access to its services. This strategic collaboration is expected to enhance patient referral networks and drive additional revenue streams for the company. The ongoing expansion into new geographic markets is also a key component of Lumexa's strategy, with plans to open additional clinics in underserved areas across the Southeast.
In summary, Lumexa Imaging's preliminary unaudited results for 2025 reveal a strong financial performance, with significant growth in revenues and a positive outlook for 2026. The company is well-positioned to capitalize on the increasing demand for outpatient imaging services, backed by strategic expansions and technological innovations. With a scheduled earnings conference call on March 15, stakeholders will have the opportunity to gain further insights into Lumexa's promising future.
Originally reported by Menafn. View original.